Clinical Trials Logo

Postoperative Pain clinical trials

View clinical trials related to Postoperative Pain.

Filter by:

NCT ID: NCT00790829 Terminated - Postoperative Pain Clinical Trials

Preemptive Use of the Nicotine Patch for Postoperative Pain Relief After Open Abdominal Surgery

Start date: August 2007
Phase: N/A
Study type: Interventional

The efficacy of a low dose nicotine patch of seven milligrams placed before surgery and its effect on decreasing pain after surgery is the main purpose of the study.

NCT ID: NCT00746720 Terminated - Pain Clinical Trials

Modulation of the Surgical Inflammatory Response by Etoricoxib

Start date: May 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test the hypothesis that orally administered etoricoxib (COX-2) modulates prostaglandin and cytokine synthesis in the central nervous system (CNS) and in the periphery in surgical patients and thus reduces pain and suffering.

NCT ID: NCT00720343 Terminated - Postoperative Pain Clinical Trials

Effect of Oral Choline Supplementation on Postoperative Pain

Start date: February 2009
Phase: Phase 4
Study type: Interventional

This research will test whether consuming additional choline before gynecological surgery decreases postoperative pain.

NCT ID: NCT00712517 Terminated - Postoperative Pain Clinical Trials

Propofol Versus Volatile Anesthesia in Post Operative Pain Management

Start date: September 2010
Phase: N/A
Study type: Interventional

The study will test the hypothesis that patients anesthetized with propofol suffer less postoperative pain than those anesthetized with sevoflurane.

NCT ID: NCT00638404 Terminated - Pain Clinical Trials

Severity Postoperative Pain Prediction

Start date: August 2007
Phase:
Study type: Observational

A simple preoperative evaluation assessing level of anxiety, anticipated pain, and intensity rating of audio tone will predict the severity of postoperative pain after surgery.

NCT ID: NCT00616824 Terminated - Postoperative Pain Clinical Trials

The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction

Start date: September 2007
Phase: Phase 4
Study type: Interventional

This study intends to compare postoperative outcomes of a tissue expander placement following a mastectomy with two different operative techniques. This study will be randomized and double blinded comparing the traditional placement of the tissue expander under an inferolateral serratus muscle flap to a new technique which uses an acellular dermal matrix as an inferolateral sling, instead of the muscle flap. The study we are proposing will evaluate the question of whether there is a difference between the traditional method of serratus flap and the new technique of using an acellular matrix with tissue expander placement. This will be a double blinded randomized study of thirty women in each group comparing outcomes which will include postoperative pain, complications (wound infection, hematoma, capsular contracture, etc), and patient satisfaction with the procedure.

NCT ID: NCT00403806 Terminated - Postoperative Pain Clinical Trials

Dexamethasone for Paediatric Adeno-tonsillectomy - A Dose-finding Study

Start date: February 2005
Phase: Phase 4
Study type: Interventional

Adeno-tonsillectomy is a commonly performed surgical procedure in children. Main morbidities are postoperative pain, nausea and vomiting, and haemorrhage. Non-steroidal anti-inflammatory drugs (NSAIDs)widely used for paincontrol increase the risk of postoperative bleeding and reoperation. Dexamethasone is an powerful antiemetic and has shown analgesic efficacy. Antiemetic and analgesic dose-response has never been established.

NCT ID: NCT00403234 Terminated - Postoperative Pain Clinical Trials

Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement

Start date: November 2006
Phase: Phase 2
Study type: Interventional

The objectives in this study are to evaluate: (1) efficacy of buprenorphine transdermal system (BTDS, Butrans™) on postoperative pain following total knee replacement surgery; (2) the impact of BTDS on functional rehabilitative measures after total knee replacement surgery; and 3) the safety of BTDS after total knee replacement surgery. The double-blind treatment period is for 28 days during which time supplemental analgesic medication will be provided to all subjects in addition to study drug. Purdue Pharma L.P. terminated the trial early due to administrative reasons not related to efficacy or safety. The focus of this study became safety evaluations.